KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 76 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,115 | +7.0% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $94,500 | -41.4% | 10,500 | -48.8% | 0.00% | -50.0% |
| Q1 2023 | $161,130 | -65.1% | 20,500 | -66.1% | 0.00% | -63.6% |
| Q1 2020 | $462,000 | -57.1% | 60,400 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $1,076,000 | -37.3% | 60,400 | +0.7% | 0.01% | -33.3% |
| Q1 2019 | $1,717,000 | +44.9% | 60,000 | 0.0% | 0.02% | +31.2% |
| Q4 2018 | $1,185,000 | +30.7% | 60,000 | +46.3% | 0.02% | +77.8% |
| Q3 2018 | $907,000 | +172.4% | 41,000 | 0.0% | 0.01% | +200.0% |
| Q2 2018 | $333,000 | -14.4% | 41,000 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $389,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |